TY - JOUR
T1 - Emerging infectious diseases
T2 - Focus on infection control issues for novel coronaviruses (Severe Acute Respiratory Syndrome-CoV and Middle East Respiratory Syndrome-CoV), hemorrhagic fever viruses (Lassa and Ebola), and highly pathogenic avian influenza viruses, A(H5N1) and A(H7N9)
AU - Weber, David J.
AU - Rutala, William A.
AU - Fischer, William A.
AU - Kanamori, Hajime
AU - Sickbert-Bennett, Emily E.
N1 - Funding Information:
Funding/support: Supported by the University of North Carolina at Chapel Hill ( U54CK000164 ).
Publisher Copyright:
© 2016 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.
PY - 2016/5/2
Y1 - 2016/5/2
N2 - Over the past several decades, we have witnessed the emergence of many new infectious agents, some of which are major public threats. New and emerging infectious diseases which are both transmissible from patient-to-patient and virulent with a high mortality include novel coronaviruses (SARS-CoV, MERS-CV), hemorrhagic fever viruses (Lassa, Ebola), and highly pathogenic avian influenza A viruses, A(H5N1) and A(H7N9). All healthcare facilities need to have policies and plans in place for early identification of patients with a highly communicable diseases which are highly virulent, ability to immediately isolate such patients, and provide proper management (e.g., training and availability of personal protective equipment) to prevent transmission to healthcare personnel, other patients and visitors to the healthcare facility.
AB - Over the past several decades, we have witnessed the emergence of many new infectious agents, some of which are major public threats. New and emerging infectious diseases which are both transmissible from patient-to-patient and virulent with a high mortality include novel coronaviruses (SARS-CoV, MERS-CV), hemorrhagic fever viruses (Lassa, Ebola), and highly pathogenic avian influenza A viruses, A(H5N1) and A(H7N9). All healthcare facilities need to have policies and plans in place for early identification of patients with a highly communicable diseases which are highly virulent, ability to immediately isolate such patients, and provide proper management (e.g., training and availability of personal protective equipment) to prevent transmission to healthcare personnel, other patients and visitors to the healthcare facility.
KW - Ebola viral disease
KW - Emerging infectious diseases
KW - Lassa fever
KW - Middle East respiratory syndrome
KW - health care-associated infections
KW - infection control
KW - novel influenza viruses
KW - occupational health
KW - severe acute respiratory disease
UR - http://www.scopus.com/inward/record.url?scp=84971644025&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84971644025&partnerID=8YFLogxK
U2 - 10.1016/j.ajic.2015.11.018
DO - 10.1016/j.ajic.2015.11.018
M3 - Article
C2 - 27131142
AN - SCOPUS:84971644025
SN - 0196-6553
VL - 44
SP - e91-e100
JO - American Journal of Infection Control
JF - American Journal of Infection Control
IS - 5
ER -
